Our leadership team
As CEO of SYNLAB UK & Ireland, Mark is responsible for strategic direction and all operational activities across the business. He oversees each of the organisation’s four joint venture partnerships including all 3000 employees providing pathology services across the country.
Before joining SYNLAB in 2017 Mark was a founding member of the management team at Virgin Care, undertaking roles spanning the corporate and regional operations sphere and all things in between.
Prior to entering the Healthcare arena he served for 10 years in the British Army with the Household Cavalry before leaving as a Major.
He has a BSc (Hons) from Reading University in Land Management (Development).
Deputy Chief Executive Officer
Tom is Deputy CEO of SYNLAB UK & Ireland, and CEO of Synnovis, SYNLAB’s joint venture partnership in South East London.
Until January 2026 Tom served as Chief Financial Officer of SYNLAB UK & Ireland, after joining the business in March 2018 from Capita Plc where he held a number of senior Finance Director roles.
ACA qualified with Deloitte, he previously worked as an Equity Analyst for JPMorgan and Gartmore Investment Management focusing on the European utilities market. Tom graduated from UCL with a BSc in Statistics.
As Chief Commercial Officer, Selina is responsible for all contracts and commercial arrangements with customers and suppliers, as well as overseeing legal matters for SYNLAB UK & Ireland.
A Chartered Accountant and Admitted Solicitor, Selina has extensive commercial experience in both the public and private health sectors. Prior to joining SYNLAB UK & Ireland in 2011, Selina was Head of Commercial for the Department of Health’s NHS Contracting Division, managing deals with private sector entities.
Greg joined SYNLAB UK and Ireland in 2025, and is responsible for the strategic and operational development, management and planning of the HR & OD portfolio. He has more than 30 years of experience in HR, working across many industries, including public sector, not for profit, retail, telecommunications, manufacturing, utilities and outsourcing.
Most recently, he spent 12 years with Sodexo Health & Care as HR & HSE Director, responsible for HR, Learning and Development, Health and Safety, Social Value and Industrial Relations.
Greg is a Member of the Chartered Institute of Personnel & Development and has an MA in HR Management.
As Chief Medical Officer, John is responsible for the advancement of our clinical strategy, and ensuring the organisation remains at the forefront of advancing diagnostics in the UK. He joined our team in April 2026, bringing with him significant experience in senior leadership roles, most recently as Chief Medical Officer at AXA. He also spent more than 20 years as an NHS GP Partner and Trainer where he contributed to clinical governance, prescribing, safeguarding and service redesign.
John holds degrees from University of Cambridge in Natural Sciences and University of Oxford in Medicine. His early hospital career spanned neurosurgery, trauma, intensive care, psychiatry and paediatrics, followed by a move into emergency medicine and later general practice.
Joining SYNLAB UK & Ireland as Chief Operating Officer in January 2026, Saghar oversees complete operational life-cycle management across the organisation’s large portfolio of laboratory diagnostic businesses. She draws on a distinguished career of more than 28 years to drive excellence, with a strong emphasis on innovation, collaboration and high-quality outcomes.
Saghar holds a Master’s and Professional Doctorate in Biomedical Science, an Executive MBA and Chartered Manager status, demonstrating her commitment to continuous learning and ability to unite scientific rigour with business acumen. She has previously served as Managing Director for two large pathology joint ventures, where her leadership earned significant recognition both nationally and internationally.
Jamie is responsible for the financial strategy, direction and portfolio of SYNLAB UK & Ireland. He is a highly commercial and strategic finance leader with a background of working for and with organisations ranging from SMEs to blue-chip giants, including in mainland Europe and the USA.
He joined the SYNLAB UK & I team in 2021 with experience in privately owned, private equity and public companies in sectors such as digital services, technology outsourcing and consultancy, aerospace, healthcare and regulated businesses. He also has significant expertise in leading teams through large, complex transformation programmes and in driving business improvement.
As Chief information Officer, Jo is responsible for information technology strategy, development and support. She is driving forward an integrated IT Strategy and developing our IT maturity, ensuring our processes and technology adoption initiatives support our strategy and enable business growth.
Jo joined SYNLAB IN 2024 with more than 20 years’ experience in IT system implementation, development and delivery, spending the majority of her career in the geospatial industry as CTO for Ordnance Survey and most recently as Solutions Engineering Director for RS Group.
Jo is also the appointed Senior Information Risk Owner (SIRO) for SYNLAB UK & Ireland and Synnovis.
As Chief of Staff for SYNLAB UK & Ireland, Robert works with the Executive and senior leadership teams to deliver the organisation’s Vision and Strategic Priorities, and leads on Sustainability and ESG.
He joined SYNLAB in 2012 and managed the transformation of pathology services in Somerset. Throughout the intervening years he has supported rapid organisational growth through a number of key roles including as Head of Transformation and Chief Operating Officer.
He has wide-ranging experience in both the public and private sector and believes strongly in the benefits of collaboration and partnership. He holds a Master’s in Sustainability.
Dominic is Chief Scientific Officer for SYNLAB UK & Ireland, responsible for improving care for the patients of tomorrow through innovation, research, and development of pathology services throughout the United Kingdom.
He identifies and facilitates innovation which will shape the future of diagnostic testing, and is a key supporter of the development of scientists across the organisation.
He is a visiting professor at the School of Biosciences and Medicine at the University of Surrey, and has an honorary academic position at King’s College London. He has published extensively in his field of speciality, the development and application of biomarkers for the assessment of vitamin status, and 2001 founded the Synnovis Human Nutristasis Unit to further this work.
